Cardioid | Jotup

EQS-News: HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery

Retrieved on:

Tuesday, November 7, 2023

Data analysis, Drug, Heart, Physiology, AG, Fibrosis, Drug development, Myocardial infarction, Drug discovery, Partnership, CFO, Molecular Devices, Death, Private equity fund, Cardioid, Medical device, Pharmaceutical industry, Cryptocurrency

The financing enables the completion of a ready-to-use, fully integrated, automated, high-throughput Cardioid Drug Discovery Platform for proprietary and collaborative drug discovery programs in indications with a high medical need such as drug-induced and genetic cardiomyopathies as well as myocardial infarction and fibrosis.

Key Points:

The financing enables the completion of a ready-to-use, fully integrated, automated, high-throughput Cardioid Drug Discovery Platform for proprietary and collaborative drug discovery programs in indications with a high medical need such as drug-induced and genetic cardiomyopathies as well as myocardial infarction and fibrosis.
HeartBeat.bio’s Cardioid Drug Discovery Platform facilitates the transition from traditional pre-clinical development to an animal-free, human-centric drug discovery approach.
This new Cardioid Drug Discovery Platform approach starts from target identification and validation, disease modeling, hit identification and confirmation up to lead compound development, drug profiling and finally clinical trials-in-a-dish.
Along with high-content-imaging and AI-based software, the Cardioid Drug Discovery Platform is designed to develop first-in-class drugs faster, less expensively and with a higher clinical success rate.

Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries

Retrieved on:

Monday, October 16, 2023

SAN JOSE, Calif., Oct. 16, 2023 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), has launched the CellXpress.ai™ Automated Cell Culture System—an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab. The visionary goal for this instrument is to reduce reliance on animal models in drug development while enhancing productivity, optimizing efficiency, and fast-tracking potential therapeutics to pre-clinical trials using human-relevant models earlier in the process.

Key Points:

"In drug discovery, we recognize the significance of having advanced cell culture protocols for 3D biology models," said Shantanu Dhamija, Vice President of Strategy and Innovation Molecular Devices.
Key features of the CellXpress.ai cell culture system include:
Reduce Labor Costs: Until now, large-scale cell culture has demanded round-the-clock oversight.
The CellXpress.ai cell culture system uses automation and AI to maintain this 24/7 schedule, improving workflows and making assays more reliable and reproducible.
To learn more or to join a community of researchers at the forefront of innovation using the CellXpress.ai cell culture system, visit CellXpressAI.com .

YEYIAN GAMING Launches Epic PC Promotions and Over $2,000 Prizes for Intel Gamer Days 2023

Retrieved on:

Thursday, August 24, 2023

Assassin's Creed Mirage, Partnership, MSRP, RTX 4090, Innovation, PC, Computer, Intel Core, Defense Red Switch Network, Personal computer, NVIDIA, Cardioid, Intel, Community engagement, Video game, Kunai

SAN DIEGO, Aug. 24, 2023 /PRNewswire-PRWeb/ -- YEYIAN GAMING, a pioneering force in the gaming industry, has set the stage for an electrifying collaboration with Intel during the much-anticipated Intel Gamer Days 2023. From August 24 to September 3, gamers and enthusiasts alike are in for an unprecedented treat as YEYIAN GAMING joins forces with Intel to unveil an array of spectacular promotions on select gaming PCs powered by 13th Gen Intel Core processors. The offer includes free Nightingale and Assassin's Creed Mirage game bundles, jaw-dropping discounts, and an exhilarating giveaway with over $2,000 worth of prizes, elevating the gaming experience to a whole new level.

Key Points:

Partnering for Innovation and Excellence: YEYIAN GAMING and Intel Join Forces
This monumental partnership signifies YEYIAN GAMING's unwavering commitment to innovation and excellence in the gaming realm.
"We are thrilled to partner with Intel Gamer Days for this dynamic co-marketing campaign," said Frank Lee, VP at YEYIAN GAMING.
As the excitement of Intel Gamer Days sweeps the gaming world, YEYIAN GAMING is proud to host a thrilling giveaway, offering gamers the chance to win prizes worth over $2,000.
YEYIAN GAMING and Intel Gamer Days 2023 invite gamers, enthusiasts, and tech aficionados to embark on an exhilarating journey into the future of gaming.

Camera Microphone Market to Expand at a CAGR of 6.5% during 2023-2031 | Growth Market Reports

Retrieved on:

Wednesday, June 7, 2023

Online, DSLR, Mono, Omnidirectional, Completeness, Key, Cardioid, News, RF, Wireless, Retail, Online shopping, Cassette tape, Mobile phone, Bidirectional, Shotgun, Growth, Forecast

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.

Key Points:

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.
It provides an in-depth analysis of the market segments, which include type, microphone subcategory, polar pattern, application, distribution channel, and competitor analysis.
Moreover, it provides crucial strategies that are helping market players to expand their market share.
For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5211
On the basis of region, the global camera microphone market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Camera Microphone Market to Expand at a CAGR of 6.5% during 2023-2031 | Growth Market Reports

Retrieved on:

Wednesday, June 7, 2023

Online, DSLR, Mono, Omnidirectional, Completeness, Key, Cardioid, News, RF, Wireless, Retail, Online shopping, Cassette tape, Mobile phone, Bidirectional, Shotgun, Growth, Forecast

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.

Key Points:

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.
It provides an in-depth analysis of the market segments, which include type, microphone subcategory, polar pattern, application, distribution channel, and competitor analysis.
Moreover, it provides crucial strategies that are helping market players to expand their market share.
For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5211
On the basis of region, the global camera microphone market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

EQS-News: HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases

Retrieved on:

Wednesday, October 5, 2022

The collaboration aims to accelerate development of new therapy options and achieve better outcomes for people with heart diseases.

Key Points:

The collaboration aims to accelerate development of new therapy options and achieve better outcomes for people with heart diseases.
Boehringer Ingelheim will work with the scientists from HeartBeat.bio to further advance the companys platform using selected reference compounds from Boehringer Ingelheims research and development programs.
[1] Existing cardiac safety screening models, such as cardiomyocytes, are limited in predictability as they are not able to sufficiently recapitulate human heart physiology.
HeartBeat.bios heart organoids are stem-cell derived 3D cell culture systems, which mimic the human heart physiology in a totally new way.

DGAP-News: HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

Retrieved on:

Monday, September 12, 2022

The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices Organoid Innovation Center solutions available today.

Key Points:

The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices Organoid Innovation Center solutions available today.
The combination of HeartBeat.bios proprietary Cardioid technology and Molecular Devices automated 3D cell culture and image analysis solutions, defines a powerful and compelling partnership.
To learn more about how HeartBeat.bio and Molecular Devices technologies are helping advance drug discovery, listen to this recorded panel discussion hosted by Drug Target Review.
HeartBeat.bio AG is dedicated to developing the first high-throughput human organoid screening platform for cardiac drug discovery.

Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

Retrieved on:

Monday, September 12, 2022

SAN JOSE, Calif., and VIENNA, Sept. 12, 2022 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, have entered into a co-development agreement. With cardiovascular diseases the leading cause of death worldwide—claiming 34 lives every minute—and cardiotoxicity a leading cause of drug withdrawals, this collaboration will provide automated solutions to better model disease physiology, discover novel drug targets, and test cardiac toxicity using 3D cell cultures that more accurately represent human biology as compared to traditional animal models. The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices' Organoid Innovation Center solutions available today.

Key Points:

, a leading provider of high-performance life science solutions, and HeartBeat.bio AG , a biotech company developing cardiac organoids (Cardioids) for drug discovery, have entered into a co-development agreement.
The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices' Organoid Innovation Center solutions available today.
To learn more about how HeartBeat.bio and Molecular Devices technologies are helping advance drug discovery, listen to this recorded panel discussion hosted by Drug Target Review.
HeartBeat.bio AG is dedicated to developing the first high-throughput human organoid screening platform for cardiac drug discovery.

Creative Live! Mic M3: You won’t wanna drop this mic

Retrieved on:

Thursday, September 23, 2021

USB, Tablet, Cardioid, Multimedia, Artificial intelligence, Sound, CES, United States, Sound Blaster, Holography, Audio, Creative Technology, Technology, Mac, Anthropometry, United, US, GLOBE, Cassette tape

Milpitas, California, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Creative Technology today announced the release of Creative Live!

Key Points:

Milpitas, California, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Creative Technology today announced the release of Creative Live!
Mic M3, a plug-and-play USB microphone that allows users to record and sound like professionals while streaming, gaming, or even conferencing.
In 2016, Creative unveiled the X-Fi Sonic Carrier: a brand-new concept in hi-res audio and video delivery for home entertainment.
Creative, the Creative logo, Sound Blaster and Super X-Fi are trademarks or registered trademarks of Creative Technology Ltd in the Singapore and/or other countries.

ROCCAT’s Studio-Grade Torch Microphone for Gamers, Streamers, and Aspiring Creators Now Available Worldwide

Retrieved on:

Monday, August 16, 2021

The Torch is ROCCATs all-new USB microphone designed to deliver studio-grade performance for gamers, streamers, and aspiring creators.

Key Points:

The Torch is ROCCATs all-new USB microphone designed to deliver studio-grade performance for gamers, streamers, and aspiring creators.
ROCCATs Torch USB microphone is available today at participating retailers worldwide and from www.roccat.com for a MSRP of $99.99.
View the full release here: https://www.businesswire.com/news/home/20210816005161/en/
ROCCAT's all-new Torch USB microphone delivers studio-grade recording performance for $99.99 and is available at participating retailers worldwide.
(Photo: Business Wire)
Just like the rest of ROCCATs portfolio, the Torch is a sophisticated, intuitive, and truly unique product.